Editorial: Allostatic Load and Inflammatory Bowel Disease. Authors' Reply

被引：0
|
作者：
Zhao, Jianhui [1 ,2 ]
Xue, Erxu [3 ]
Liu, Zhanju [4 ,5 ]
Li, Xue [1 ,2 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Big Data Hlth Sci, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Sch Publ Hlth, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Nursing Dept, Hangzhou, Zhejiang, Peoples R China
[4] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Ctr Inflammatory Bowel Dis Res, Shanghai, Peoples R China
[5] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Gastroenterol, Shanghai, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2025年 / 61卷 / 01期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1111/apt.18414
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：190 / 191
页数：2
相关论文
共 50 条
  • [31] Letter: dermatological complications with therapy for inflammatory bowel disease authors' reply
    Ghosh, S.
    Moran, G. W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (02) : 233 - 234
  • [32] TPMT genotype and the response to azathioprine in inflammatory bowel disease: authors' reply
    Winter, J. W.
    Marinaki, A. M.
    Sanderson, J. D.
    Mills, P. R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (07) : 1084 - 1085
  • [33] Letter: rationalising aminosalicylates in inflammatory bowel disease-authors' reply
    Chapman, Thomas P.
    Frias Gomes, Catarina
    Louis, Edouard
    Colombel, Jean-Frederic
    Satsangi, Jack
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (10) : 1621 - 1621
  • [34] Letter: Light in the lumen-The expanding role of intestinal ultrasound for functional symptoms in inflammatory bowel disease. Authors' reply
    Mujagic, Zlatan
    Aliu, Arta
    Bosch, Daan H. C. A.
    Keszthelyi, Daniel
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (06) : 835 - 836
  • [35] Autoantibodies in inflammatory bowel disease.
    Bene, L
    Miklos, K
    Nemeth, K
    Prohaszka, Z
    Kovacs, A
    Korhaz, PS
    GASTROENTEROLOGY, 2000, 118 (04) : A1333 - A1333
  • [36] Hypercoagulability in Inflammatory bowel disease.
    Bulchandani, D.
    Nachnani, J.
    Allen, M.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S31 - S31
  • [37] Editorial: predictors of disease activity during pregnancy in women with inflammatory bowel disease - a Danish cohort study. Authors' reply
    Vestergaard, Thea
    Kelsen, Jens
    Julsgaard, Mette
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (03) : 351 - 352
  • [38] Associations between the IGF system and inflammatory markers in inflammatory bowel disease: authors' reply
    Gentilucci, UV
    Picardi, A
    Caviglia, R
    Cicala, M
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (04) : 554 - 555
  • [39] Hypercoagulability in inflammatory bowel disease.
    Becker, SA
    Goldsmith, G
    Harris, EN
    Ens, G
    GASTROENTEROLOGY, 1996, 110 (04) : A861 - A861
  • [40] Pediatric inflammatory bowel disease.
    Orenstein S.R.
    Current Gastroenterology Reports, 1999, 1 (3) : 220 - 222
12345